InsidersTradesSigma
티앤알바이오팹 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 티앤알바이오팹 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 티앤알바이오팹 has recorded 107 insider filings. Market capitalisation: €126.5bn. The latest transaction was reported on 30 June 2026 (Purchase). Among the most active insiders: 윤원수. The full history is accessible without an account.
107
Insider Decl.
n/a
Thresholds
€280,357
24 ops.
Buy Volume
n/a
3 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,817 of 28,205 companies
15.6
score / 100
Value13
Quality18
FCF yld-8.4%
Earn yld-30%
EV/EBITDA·
ROE-146%
Gross mgn26%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 June 2026
Declarations107 total
25 of 107 declarations
About 티앤알바이오팹
티앤알바이오팹 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative technologies in the biopharmaceutical field.